Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 8, 2003, Pages 3993-3996

  Ogawa, Susumu ^a   Takeuchi, Kazuhisa ^a   Ito, Sadayoshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; BUFORMIN; PIOGLITAZONE;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ATRIAL NATRIURETIC FACTOR; BODY MASS INDEX; BUFORMIN; DIABETES MELLITUS, TYPE 2; FEMALE; HEART FAILURE, CONGESTIVE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; STROKE VOLUME; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0042383369     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021765     Document Type: Article

References (8)

1. Krentz AJ, Bailey CJ, Melander A. Thiazolidinediones for type 2 diabetes. BMJ 2000; 321: 235-6.
2. Cheng-Lai A, Levine A. Rosiglitazone. An agent from the thiazolidinedione class for the treatment of type 2 diabetes. Heart Disease 2000; 2: 326-33.
3. Niemeyer NV, Janney LM. Thiazolidinedione-induced edema. Pharmacotherapy 2002; 924-929
4. Hara Y, Hamada M, Shigematsu Y et al. Effect of beta-blocker on left ventricular function and natriuretic peptides in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitor. Jpn Circ J 2000; 64: 365-9.
5. Suzuki T, Yamaoki K, Nakajima O et al. Screening for cardiac dysfunction in asymptomatic patients by measuring B-type natriuretic peptide levels. Jpn Heart J 2000; 41: 205-14.
6. Blecher G, Mathews, D.R. Safety and tolerabilityof pioglitazone. Exp Clin Endocrinol Diabetes 108 (Suppl 2): S267-S273, 2000
7. Gillies P.S., Dunn C.J. Pioglitazone. Drugs 60: 333-343, 2000
8. Fernando O. Ovalle-Berumen J. Thiazolidinediones: a review of their benefits and risks. South Med J. 95:1188-1194, 2002